Karl Leo - Net Worth and Insider Trading
Karl Leo Net Worth
The estimated net worth of Karl Leo is at least $11 Million dollars as of 2024-11-13. Karl Leo is the 10% Owner of Monopar Therapeutics Inc and owns about 642,392 shares of Monopar Therapeutics Inc (MNPR) stock worth over $11 Million. Details can be seen in Karl Leo's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Karl Leo has not made any transactions after 2019-12-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Karl Leo
Karl Leo Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Karl Leo owns 1 companies in total, including Monopar Therapeutics Inc (MNPR) .
Click here to see the complete history of Karl Leo’s form 4 insider trades.
Insider Ownership Summary of Karl Leo
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MNPR | Monopar Therapeutics Inc | 2019-12-18 | 10 percent owner |
Karl Leo Latest Holdings Summary
Karl Leo currently owns a total of 1 stock. Karl Leo owns 642,392 shares of Monopar Therapeutics Inc (MNPR) as of December 18, 2019, with a value of $11 Million.
Latest Holdings of Karl Leo
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MNPR | Monopar Therapeutics Inc | 2019-12-18 | 642,392 | 17.66 | 11,344,643 |
Holding Weightings of Karl Leo
Karl Leo Form 4 Trading Tracker
According to the SEC Form 4 filings, Karl Leo has made a total of 1 transactions in Monopar Therapeutics Inc (MNPR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Monopar Therapeutics Inc is the acquisition of 31,313 shares on December 18, 2019, which cost Karl Leo around $1 Million.
Insider Trading History of Karl Leo
- 1
Karl Leo Trading Performance
Karl Leo Ownership Network
Ownership Network List of Karl Leo
Ownership Network Relation of Karl Leo
Karl Leo Owned Company Details
What does Monopar Therapeutics Inc do?
Who are the key executives at Monopar Therapeutics Inc?
Karl Leo is the 10 percent owner of Monopar Therapeutics Inc. Other key executives at Monopar Therapeutics Inc include Chief Operating Officer Andrew Cittadine , Chief Financial Officer Kim R Tsuchimoto , and director & Chief Executive Officer Chandler Robinson .
Monopar Therapeutics Inc (MNPR) Insider Trades Summary
Over the past 18 months, Karl Leo made no insider transaction in Monopar Therapeutics Inc (MNPR). Other recent insider transactions involving Monopar Therapeutics Inc (MNPR) include a net purchase of 128,508 shares made by Andrew Cittadine , and a net purchase of 1,550 shares made by Karthik Radhakrishnan .
In summary, during the past 3 months, insiders sold 0 shares of Monopar Therapeutics Inc (MNPR) in total and bought 1,550 shares, with a net purchase of 1,550 shares. During the past 18 months, 0 shares of Monopar Therapeutics Inc (MNPR) were sold and 27,252 shares were bought by its insiders, resulting in a net purchase of 27,252 shares.
Monopar Therapeutics Inc (MNPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Monopar Therapeutics Inc Insider Transactions
Karl Leo Mailing Address
Above is the net worth, insider trading, and ownership report for Karl Leo. You might contact Karl Leo via mailing address: C/o Gem Pharmaceuticals, 200 Randolph Ave., Huntsville Al 35801.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
